Pay in 4 interest-free payments of $6.12 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Keep it refrigerated and set aside until you hear back
Example: I12.9 (Hypertensive CKD) N18.3 (CKD Stage 3) I16.1 (Emergency)
Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer
Expiration Date 07/31/2028 00:00:00 UPC 850047947772 Ingredients Hypromellose (capsule), vegetable magnesium stearate, silicon dioxide, microcrystalline cellulose
Not approved for diagnostic or therapeutic purposes
Contrasting endocrine responses to acute oral compared with intravenous sodium loading in normal humans
US$ 25.51
US$ 27.80
US$ 26.64
